Analysts Set 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Price Target at $26.71
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has earned an average rating of “Moderate Buy” from the ten analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating on […]
More Stories
Who is Yeonjun? Band, Age, Albums, and Updates
One of the eldest and all-around band members of TXT (TOMORROW X TOGETHER), Yeonjun. He is the only member born...
Skip the Spa: Achieving Relaxation with a Backyard Sauna Kit
A luxurious spa visit is no longer necessary for those seeking a tranquil and calming environment for relaxation. Many homeowners...
Types of Kitchen Faucets: A Quick Buyer’s Guide to Find the Perfect Sink Fit
Choosing kitchen faucets can be a little decision to make, yet it can have a tremendous impact on the appearance...
Significant Increase in the Circulation of Counterfeit Bills in Retail Stores
By The Canadian Press The Retail Council of Canada is sounding the alarm about the significant increase in circulation of...
White House Economist Proposal Coming Soon on $2,000 Tariff Rebate Checks
By Jack Phillips A top White House economic official said that it appears more and more likely that the Trump...
Malicious Actors Impersonating Senior US Officials, FBI Warns
By Naveen Athrappully Malicious actors are impersonating government officials to secure sensitive information and steal funds, the FBI said in...